BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12

• Press Releases

  Newron Begins Enrollment in Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-Resistant Schizophrenia (TRS)

  August 12, 2025

   · 

  9 min read
• Press Releases

  Acurx Pharmaceuticals, Inc. Reports Second Quarter 2025 Results and Provides Business Update

  August 12, 2025

   · 

  11 min read
• Press Releases

  NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues

  August 12, 2025

   · 

  9 min read
• Press Releases

  AN2 Therapeutics Commences First-in-Human Clinical Trial of Oral AN2-502998 for Chagas Disease

  August 12, 2025

   · 

  5 min read
• Press Releases

  NodThera Demonstrates Reversal of Neuroinflammation and Inflammation in Parkinson’s Disease with Oral NLRP3 Inhibitor

  August 12, 2025

   · 

  5 min read
• Press Releases

  Abcentra LLC Announces First Patient Dosed in Phase 2b “FORTIFY” Clinical Trial Evaluating Orticumab in Patients with Cardiovascular Disease

  August 12, 2025

   · 

  3 min read
• Press Releases

  Bruker Announces Quarterly Dividend - August 12, 2025

  August 12, 2025

   · 

  2 min read
• Press Releases

  Xspray Pharma Signs License Agreement with Handa Therapeutics – to Receive up to Double-Digit Royalty on Handa’s Net Proceeds

  August 12, 2025

   · 

  1 min read
• Press Releases

  Apriori Bio Announces Collaboration with the Francis Crick Institute

  August 12, 2025

   · 

  3 min read
• Press Releases

  PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases

  August 12, 2025

   · 

  8 min read